Western University

Scholarship@Western
Paediatrics Publications

Paediatrics Department

5-1-2011

Maternal Protein Restriction Elevates Cholesterol in Adult Rat
Offspring Due to Repressive Changes in Histone Modifications at
the Cholesterol 7α-Hydroxylase
7 -Hydroxylase Promoter
Gurjeev Sohi
Kelly Marchand
Andrew Revesz
Edith Arany
Daniel B. Hardy

Follow this and additional works at: https://ir.lib.uwo.ca/paedpub
Part of the Pediatrics Commons

ORIGINAL

RESEARCH

Gurjeev Sohi, Kelly Marchand, Andrew Revesz, Edith Arany, and Daniel B. Hardy
Department of Physiology & Pharmacology (G.S., D.B.H.) and Department of Obstetrics & Gynecology
(G.S., A.R., D.B.H.), The University of Western Ontario, London, Ontario, Canada, N6A 5C1; The
Children’s Health Research Institute (G.S., A.R., D.B.H.), London, Ontario, Canada, N6A 5C1; and The
Lawson Health Research Institute (G.S., K.M., A.R., E.A., D.B.H.), London, Ontario, Canada, N6A 4V2

Adverse events in utero, such as intrauterine growth restriction (IUGR), can permanently alter
epigenetic mechanisms leading to the metabolic syndrome, which encompasses a variety of symptoms including augmented cholesterol. The major site for cholesterol homeostasis occurs via the
actions of hepatic cholesterol 7␣-hydroxylase (Cyp7a1), which catabolizes cholesterol to bile acids.
To determine whether posttranslational histone modifications influence the long-term expression
of Cyp7a1 in IUGR, we used a protein restriction model in rats. This diet during pregnancy and
lactation led to IUGR offspring with decreased liver to body weight ratios, followed by increased
circulating and hepatic cholesterol levels in both sexes at d 21 and exclusively in the male offspring
at d 130. The augmented cholesterol was associated with decreases in the expression of Cyp7a1.
Chromatin immunoprecipitation revealed that this was concomitant with diminished acetylation
and enhanced methylation of histone H3 lysine 9 [K9,14], markers of chromatin silencing, surrounding the promoter region of Cyp7a1. These epigenetic modifications originate in part due to
dietary-induced decreases in fetal hepatic Jmjd2a expression, a histone H3 [K9] demethylase.
Collectively, these findings suggest that the augmented cholesterol observed in low-protein dietderived offspring is due to permanent repressive posttranslational histone modifications at the
promoter of Cyp7a1. Moreover, this is the first study to demonstrate that maternal undernutrition leads to long-term cholesterol dysregulation in the offspring via epigenetic mechanisms.
(Molecular Endocrinology 25: 785–798, 2011)

H

igh circulating cholesterol, in addition to hypertension, central obesity, and insulin resistance, characterizes the metabolic syndrome and remains an important
cardiovascular risk factor in adults (1, 2). The major site
for the regulation of cholesterol homeostasis occurs in the
liver, mainly through the conversion of cholesterol to bile
acids, via the rate-limiting enzyme cholesterol 7␣-hydroxylase (Cyp7a1) (3). The expression of Cyp7a1 is under the
regulation of the orphan nuclear receptor, the liver X
receptor (LXR) (4). Male and female mice deficient in
Cyp7a1 have elevated circulating cholesterol and de-

creased low-density lipoprotein (LDL) receptors, collectively leading to a proatherogenic phenotype (5). Although current therapies using the statin class of lipidlowering drugs have been successful in treating patients
with high cholesterol (6), some patients experience adverse side effects such as rhabdomyolysis (7). Thus, additional novel strategies are warranted to prevent the onset
of hypercholesterolemia and reduce the long-term use of
these drugs.
Clinical studies in humans have demonstrated that
adverse events in utero that result in placental insuffi-
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homeobox 1 (Pdx1), a critical transcription factor regulating ␤-cell differentiation. This included both deacetylation and hypermethylation of histone H3 [K9] (27).
Recently it was demonstrated that in a model of a LP diet
during pregnancy, LXR␣ expression was suppressed in
the fetal liver as a result of DNA hypermethylation at the
LXR␣ promoter (22); however the long-term effects of
this diet on LXR-target genes (e.g. Cyp7a1) in postnatal
life were not examined. In addition, the effects of a lowprotein diet on posttranslational histone modifications
during liver development have never been explored.
In the present study, we tested the hypothesis that a LP
diet in pregnancy may impair cholesterol homeostasis
long term via repressive changes to histone modifications
throughout development in a promoter-specific manner.
We observed whether the timing of the LP diet throughout pregnancy and lactation led to increases in circulating
cholesterol in both early (3 wk) and late (18 wk) postnatal
life. To accomplish this, four dietary regimes (Control;
Low Protein, LP1–LP3) were employed to assess the effects of a LP diet throughout life (LP1), until the end of
lactation (LP2), and exclusively during gestation (LP3).
By examining all three LP dietary regimes, it is possible to
assess the impact of the duration of the LP diet and the
timing of protein restoration on liver development and
circulating cholesterol. Given that Cyp7a1 plays a major
role in regulating cholesterol catabolism in the liver, we
also demonstrated whether changes in circulating cholesterol were linked to alterations in Cyp7a1 expression.
Finally, we investigated whether any changes to Cyp7a1
expression in fetal and postnatal life were due to differences in the acetylation and trimethylation of histone H3
[K9] surrounding the Cyp7a1 promoter.

Results
A LP diet during pregnancy and lactation leads to
impaired body weight and liver growth
A LP diet during pregnancy has been previously demonstrated to decrease birth weight (16 –19) and lead to
increases in visceral fat, impaired glucose tolerance, and
symptoms of type II diabetes in adulthood (28 –31) in the
rat offspring. Although others have demonstrated that
offspring derived from this LP dietary regime were not
hypertensive at 4 wk of age (32), LP females placed on a
high-carbohydrate diet after lactation exhibited elevated
systolic blood pressure at 1 yr of age (33). In this study, a
LP diet resulted in a significant decrease in fetal to placental weight ratio and a marked decrease in fetal liver to
body weight ratio at embryonic d 19 (Table 1). In agreement with previous reports (34, 35), a LP diet did not alter
maternal food intake, and there was no observed change
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ciency-induced intrauterine growth restriction (IUGR,
representing 8% of newborns), can also alter physiological processes leading to the metabolic syndrome (8,
9). Moreover, 50% of metabolic syndrome-related diseases can be linked to adverse events in utero (10 –12).
With respect to cholesterol, David Barker and colleagues (13, 14) have demonstrated that impaired fetal
growth is linked to elevated LDL cholesterol and hypertension in adult humans. Moreover, the association
between birth weight and cholesterol was more apparent in males and independent of social class, current
body weight, cigarette smoking, and alcohol consumption (13). Given that hypercholesterolemia in mothers
is associated with increased incidence of aortic fatty
streaks in fetal and adolescent life (15), it is conceivable
that postnatal cholesterol concentrations may be altered by the perinatal environment, although the underlying molecular mechanisms are unknown.
Various animal models have broadened our understanding of how early nutrition in pregnancy may influence liver development (16 –19). The majority of
studies have demonstrated that maternal nutrient or
protein restriction leads to decreased liver growth (16 –
19). Other studies have demonstrated that a low-protein (LP) diet during pregnancy and lactation leads to
asymmetrical IUGR (20), associated with alterations in
hepatic glucose output, decreased glucagon receptor
and glucokinase expression, along with increases in
insulin degradation and hepatic lobular volume (16,
17). However, very little is known about how maternal
nutrition may alter cholesterol homeostasis in postnatal life. In one study, maternal dietary iron restriction
led to a 21% decrease in fetal growth and an increase in
fetal liver cholesterol (21). This was further associated
with decreased expression of Cyp7a1 (21). More recently, a LP diet throughout pregnancy in mice was demonstrated to lead to reduced LXR␣ expression at embryonic d 19.5 (22); however the long-term effects of this in
utero nutritional insult on cholesterol homeostasis in
postnatal life remain elusive.
Although transcriptional changes may mediate the expression of target genes involved in fetal programming,
there is limited knowledge on the links between epigenetic
mechanisms in utero and the long-term expression of hepatic target genes (18, 19, 23, 24). Previous studies have
demonstrated that diminished acetylation and/or an increased methylation of histone H3 lysine 9 [K9,14] has
been associated with chromatin silencing and decreased
RNA polymerase II binding (25, 26). Elegant studies by
Park et al. (27) have demonstrated that uterine ligationinduced IUGR rat offspring developed type 2 diabetes as
a result of epigenetic silencing of pancreatic and duodenal
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TABLE 1. The effect of LP dietary regimes LP1, LP2, LP3 on liver growth and body weight in rat offspring at
embryonic day 19 (e19), postnatal day 21 (d21), and postnatal day 130 (d130)
d21
e19

Male

Female

Male

Female

5.67 ⫾ 0.30
4.87 ⫾ 0.18a
N/A
N/A

50.30 ⫾ 1.15
25.63 ⫾ 0.75a
N/A
48.00 ⫾ 2.17

48.87 ⫾ 1.49
25.63 ⫾ 0.91a
N/A
47.44 ⫾ 1.38

565.50 ⫾ 8.21
469.10 ⫾ 14.00a
511.1 ⫾ 12.8a
579.00 ⫾ 18.74

348.20 ⫾ 9.64
281.40 ⫾ 8.05a
298.0 ⫾ 7.3a
362.70 ⫾ 13.53

0.091 ⫾ 0.004
0.056 ⫾ 0.006a
N/A
N/A

0.0391 ⫾ 0.001
0.033 ⫾ 0.001a
N/A
0.0360 ⫾ 0.001

0.0386 ⫾ 0.001
0.034 ⫾ 0.001a
N/A
0.0384 ⫾ 0.001

0.0314 ⫾ 0.001
0.033 ⫾ 0.001
0.0330 ⫾ 0.001
0.0306 ⫾ 0.001

0.0317 ⫾ 0.001
0.031 ⫾ 0.001
0.0307 ⫾ 0.001
0.0302 ⫾ 0.001

Dietary regimes and the liver to body weight ratio of offspring. To assess body weight (g), the fetal to placental weight ratio was determined for
offspring killed at e19, and the body weight was determined for offspring killed at d21 and d130. To assess liver growth, liver to body weight ratio
was determined for all three developmental time points. All data was expressed as SEM. For e19, dietary effects were determined using Student’s
unpaired t test whereas for d21 and d130, a one-way ANOVA followed by a Bonferroni’s Multiple Comparison post hoc test was performed.
a
Significant difference (P ⬍ 0.05) vs. control (n ⫽ 10 –14/group). N/A refers to when the LP dietary regimes were the same.

in litter size or sex ratio (data not shown). To further
examine the effect of the timing and duration of the lowprotein diet on postnatal growth and liver development,
various dietary regimes (LP1, LP2, LP3) were implemented (Table 1). At d 21, there was a significant decrease
in both body weight and liver to body weight ratio in the
male and female offspring derived from the LP1/LP2 diet
compared with control (Table 1). However, offspring of
either sex derived from the LP3 dietary regime displayed
no difference in body weight and liver to body weight
ratios when compared with the offspring derived from the
control diet. We next observed the effects of LP1–LP3 on
liver and body growth at 130 d of age. We examined this
age based on our previous study that demonstrated sexspecific differences in glucose homeostasis at this time point
(35). Although the body weights of LP1 or LP2 male and
female offspring regimes remained significantly lower at d
130, their liver to body weight ratio was restored compared
with the control animals (Table 1). Furthermore, no change
in the food intake of the offspring was observed in the four
dietary regimes (Control, LP1–3; data not shown), suggesting that it was a difference in the protein content of the diet
and not appetite that was a primary factor in inducing any of
the observed developmental changes.
A LP diet during pregnancy and lactation leads to
augmented circulating cholesterol in both sexes in
early development and exclusively in the male
offspring in adulthood
To determine whether LP1–LP3 led to postnatal
changes in cholesterol levels, total circulating cholesterol was measured in the offspring at d 21 and d 130.
Total circulating cholesterol levels was observed to be
significantly increased in the male and female offspring

derived from the LP1/LP2 dietary regime at d 21 (Fig.
1A) and exclusively in the male offspring derived from
the LP2 dietary regime at d 130 (Fig. 1B). In addition, hepatic total cholesterol concentrations were similarly increased in male LP2 offspring at d 130 (Fig. 1C). In a small
cohort of control animals given a LP diet from birth to d 21
(reverse LP3), circulating cholesterol was not significantly
different from the control or LP3 offspring (Fig. 1A). The
increase in hepatic cholesterol in LP2 males at d 130 was not
attributed to alterations in 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase or the LDL receptor (Supplemental Fig.
1 published on The Endocrine Society’s Journals Online web
site at http://mend.endojournals.org). Furthermore, when
plasma triglycerides were measured at d 21 and d 130, there
was no statistical difference in triglyceride concentrations
between any dietary groups at both ages (data not shown).
Decreases in Cyp7a1 protein levels coincide with
the respective increases in total circulating
cholesterol levels in offspring derived from the
LP2 dietary regime at d 21 and d 130
To elucidate the underlying mechanisms for the augmented cholesterol in the LP2 offspring, immunoblot
analysis was performed to determine the protein levels of
hepatic Cyp7a1, the rate-limiting enzyme involved in the
conversion of cholesterol to bile acids, during fetal and
postnatal development. At embryonic d 19, a LP diet led
to a significant decrease in hepatic Cyp7a1 protein levels
(Fig. 2A). At d 21, both the male and female offspring
derived from the LP1/LP2 dietary regime also had significantly lower Cyp7a1 protein levels (Fig. 2, B and C),
which was associated with the augmented circulating
cholesterol observed in both sexes at this age (Fig. 1A).
Interestingly, when maternal proteins were restored to the
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gender-specific decrease in Cyp7a1 coincided with
changes in circulating and hepatic cholesterol at this age
(Fig. 1, B and C).

LP offspring during lactaction (LP3), Cyp7a1 protein levels significantly increased compared with control (Fig.
2D). Finally, when the expression of hepatic Cyp7a1 was
examined in both sexes from the LP2 dietary regime at d
130, only the male LP2 offspring exhibited significant
decreases in Cyp7a1 protein levels (Fig. 2, E and F). This

Decreased recruitment of RNA polymerase II in the
LP2 dietary regime is associated with chromatin
silencing of Cyp7a1 promoter region via
posttranslational histone modifications
It is well established that decreased acetylation
and/or an increased methylation of histone H3 [K9,14]
is associated with chromatin silencing and decreased
RNA polymerase II binding (25, 26). Therefore, to in-
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FIG. 1. The effect of different LP dietary regimes on circulating
cholesterol concentrations (mM) in rat offspring at postnatal d 21 (n ⫽
10 –14/group) in A. Results were expressed as the mean ⫾ SEM. Dietary
effects were determined using a two-way ANOVA followed by a
Bonferroni’s Multiple Comparison post hoc teand postnatal d 130 (n ⫽
10 –14/group) in B. C, The effect of LP2 on median lobe liver total
cholesterol at postnatal d 130 (n ⫽ 5– 6/groupst. **, Significant
difference (P ⬍ 0.01); *, significant difference (P ⬍ 0.05) vs. male
control; ##, significant difference (P ⬍ 0.01) vs. female control.

The LP2-induced reduction in hepatic Cyp7a1
protein in the male offspring is due to a decreased
recruitment of RNA polymerase II at the Cyp7a1
initiation site throughout fetal and
postnatal development
To explore the effects of LP2 on transcriptional mechanisms, chromatin immunoprecipitation (ChIP) was employed to examine the recruitment of RNA polymerase II
to the Cyp7a1 initiation site. Quantitative real-time PCR
was used to amplify an approximate 100-bp genomic region surrounding the TATA box and the initiation site
(Fig. 3, A, C, E, and G). This region was demonstrated to
have maximal enrichment of RNA polymerase II compared with distal sites of the Cyp7a1 promoter (Supplemental Fig. 2). At embryonic d 19, it was observed that
there was a significant decrease in the recruitment of RNA
polymerase II to the initiation site of hepatic Cyp7a1 in
the LP fetuses (Fig. 3A). Moreover, the decreased binding
of RNA polymerase II to the Cyp7a1 promoter persisted
in the LP2-derived male offspring at both d 21 and d 130
(Fig. 3, C and E). The decrease in recruitment of RNA
polymerase II was specific to the Cyp7a1 promoter region
given that no significant alterations in its recruitment
were observed at the promoter of glyceraldehyde 3-phosphate dehydrogenase (Gapdh), a housekeeping gene (Fig.
3, B, D, F, and H). ChIP performed using nonimmune IgG
displayed negligible level of binding to either the Cyp7a1
and Gapdh promoter region. The decrease in the recruitment of RNA polymerase to the promoter of Cyp7a1 in
LP2 offspring corresponded with both the decrease in
Cyp7a1 protein levels (Fig. 2, A, B, and D) and augmented cholesterol (Fig. 1, A and B). Given that there
were sex-specific differences in circulating cholesterol and
Cyp7a1 expression between males and females at d 130,
the recruitment of RNA polymerase II to the Cyp7a1 promoter was examined at that age for both sexes. Unlike the
males, ChIP revealed no corresponding differences in RNA
polymerase II binding to the promoter of Cyp7a1 in the
females at this age (Fig. 3G).
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that the protein levels of Cyp7a1
were slightly reduced (Fig. 2A).
However, a significant decrease in
the acetylation, along with an increase in the methylation of histone
H3 [K9], was observed at the hepatic Cyp7a1 promoter derived
from LP2 male offspring at both d
21 (Fig. 4, C and D) and d 130 (Fig.
4, E and F). At both ages in LP2
males, these epigenetic changes correspond exactly with the observed
decreased recruitment of RNA polymerase II in the Cyp7a1 promoter
(Fig. 3, C and E), diminished expression of Cyp7a1 (Fig. 2, B and D),
and the observed increases in circulating and hepatic cholesterol (Fig.
1, A–C). In contrast, no alterations
in the acetylation [K9,14] or methylation [K9] of histone H3 were observed at the hepatic promoter of
Gapdh at this age (Supplemental
Fig. 3). Interestingly, in d 130 females, where no differences in circulating cholesterol or Cyp7a1 expression were observed (Figs. 1B and
2E), there was also no corresponding changes in acetylation (Fig. 4G)
or methylation (Fig. 4H) surrounding the active site of Cyp7a1.
Given that the methylation of histone H3 [K9] can be influenced by
specific [K9] demethylases (36), we
next examined whether changes in
their expression facilitated the inFIG. 2. The effect of the LP2 dietary regime on hepatic Cyp7a1 protein levels in rat offspring
at embryonic d 19 (A), male (B), and female (C) rat offspring at postnatal d 21 and male (E) and
creases in the trimethlyation of hisfemale (F) rat offspring at postnatal d 130. D, The effect of LP3 dietary regime on hepatic
tone H3 [K9] associated in the LP2
Cyp7a1 protein levels in male rat offspring at postnatal d 21. Relative hepatic Cyp7a1 protein
males. We examined only the steadylevels were determined using Western blot analysis. Total membrane protein was isolated and
Cyp7a1 protein was detected on a Western blot using the Cyp7a1 primary antibody. The
state mRNA levels of those [K9] demCyp7a1 protein level was quantified using densitometry and normalized to that of ␤-actin
ethylases (Jmjd2a, Jmjd2b, Jmjd2c,
protein levels. Results were expressed as the mean ⫾ SEM. *, Significant difference (P ⬍ 0.05);
Jmjd2d) that removed trimethyl groups
n ⫽ 4 –7/group, where each n represents a single offspring derived from a different mother.
from [K9] of histone H3 (36). Realtime quantitative PCR revealed that
vestigate whether posttranslational histone modificasignificant
decreases
in the hepatic Jmjd2a mRNA were
tions influenced chromatin remodeling and RNA polymerase II recruitment to the Cyp7a1 promoter during observed only at embryonic d 19 in LP fetuses (Fig. 5A).
LP2, we employed ChIP utilizing antibodies directed No significant changes in the hepatic mRNA levels of
against histone H3 methylation [K9] and/or acetylation Jmjd2b and Jmjd2c were observed between diets at this
[K9,14]. At embryonic d 19, an increase in the acety- age, although there was a trend for a decrease in their
lation of histone H3 (Fig. 4A), but no change in trim- expression due to the LP diet (Fig. 5, B and C). The
ethylation (Fig. 4B), was observed surrounding the ac- steady-state mRNA level of all of these [K9] demethytive site of Cyp7a1 promoter. This was despite the fact lases was the same at d 21 (Fig. 5, D–F) and undetect-
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Discussion
In this study we present evidence for
the first time that a LP diet during
pregnancy and lactation led to hypercholesterolemia in both sexes at postnatal d 21, with augmented cholesterol persisting in the male offspring
at d 130. This was found to coincide
with transcriptional repression of
Cyp7a1, governed in part due to
changes in posttranslational histone
modifications surrounding the Cyp7a1
promoter during postnatal life. Moreover, LP diet-induced decreases in the steady-state levels of Jmjd2a
mRNA in utero may mediate the increased trimethylation of histone H3 [K9] associated with this promoter
at postnatal d 21 and d 130. These identified epigenetic
and transcriptional mechanisms help in further understanding the link between IUGR and long-term cholesterol

FIG. 3. The effect of the LP2 dietary regime on the in vivo RNA polymerase II (RNA Pol II)
binding at the initiation site of hepatic Cyp7a1 (A, C, E, and G) and the initiation site of
Gapdh gene (B, D, F, and H) in rat offspring at embryonic d 19 (e19), male rat offspring at
postnatal d 21, male and female rat offspring at postnatal d 130, respectively. ChIP was
carried out on snap-frozen liver tissues by immuneprecipitation with antibody specific for
RNA polymerase II. Quantification analysis on the immunoprecipitated solubilized DNA was
carried out by real-time PCR via use of primers specific for the initiation sites on the
promoter regions of hepatic Cyp7a1 and Gapdh. The relative level of immunoprecipitated
genomic DNA was normalized to the total genomic DNA. Results were expressed as the
mean ⫾ SEM.*, Significant difference (P ⬍ 0.05); n ⫽ 4 – 6/group, where each n represents
a single offspring derived from a different mother.

able at d 130 in the control and LP2 dietary regimes
(data not shown). The hepatic Jmjd2d mRNA was low
to undetectable at all ages examined. This LP diet-induced decrease in the fetal hepatic expression of this
[K9] demethylase may initiate the hypermethylation of
histone H3 surrounding the Cyp7a1 promoter observed in LP2 offspring.
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Protein restoration during
lactation (LP3 dietary regime)
enhances the recruitment of
LXR␣ to the promoter of Cyp7a1
at postnatal d 21
Given the important role of LXR␣
in the transcriptional regulation of
Cyp7a1, we next investigated whether
hepatic LXR␣ levels were altered in the
LP offspring by postnatal d 21, the earliest time point of cholesterol dysregulation and impaired Cyp7a1 expression. Intriguingly, in both LP2 and LP3
offspring, increases in total hepatic
LXR␣ protein levels (Fig. 6, A and B)
were observed. We next employed
ChIP to investigate the in vivo binding
of LXR␣ to the promoter of Cyp7a1
containing a well-characterized LXR
response element (LXRE) site. Despite
an increase in total LXR␣, LP2 offspring did not exhibit any alterations in
the binding of LXR␣ to the promoter of
Cyp7a1 at d 21 (Fig. 6C). However,
when the LP offspring received a 20%
protein diet during lactation (LP3),
LXR␣ binding was enhanced (Fig. 6D).
This is in association with restored
Cyp7a1 expression in this dietary cohort (Fig. 2D).
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identify early life dietary and/or drug intervention strategies to lower cholesterol
and reduce the incidence of the metabolic syndrome. Such strategies could reduce the long-term use of cholesterollowering drugs in adulthood.
As expected from previous studies
by others (14 –17) and in our laboratory (16 –19), a LP diet resulted in reduced fetal to placental weight, neonatal growth, and liver to body weight
ratio by postnatal d 21. Furthermore,
this decrease in body weight persisted
to adulthood (d 130) in offspring derived from a LP diet during pregnancy
and lactation, with (e.g. LP2) or without (e.g. LP1) a restoration in maternal
protein content after lactation. This
compliments previous studies suggesting that a LP diet in early development
has long-term implications on the overall growth of rats (31). The maternal
protein restriction model of IUGR in
rats is a relevant model to study the
fetal origins of adult diseases given that
amino acids play a critical role in fetal
growth (37). Moreover, given that placental insufficiency in humans can produce protein deficiency in the fetus
(38), this model share features in common with human placental insufficiency-IUGR. The impaired body weight is
due to the LP content in the diet given
that maternal food intake was similar
in all dietary regimes. Interestingly, the
liver to body weight ratio of offspring
was not significantly different at postFIG. 4. The effect of LP2 dietary regime on the in vivo level of acetylated histone H3 [K9,14]
(A, C, E, and G) and trimethylated histone H3 [K9] (B, D, F, and H) at the hepatic Cyp7a1
natal d 130 in any dietary regime, sugLXRE site in rat offspring at embryonic d 19 (e19), male rat offspring at postnatal d 21, male
gesting that the impaired liver growth
and female rat offspring at postnatal d 130, respectively. ChIP was carried out on snap-frozen
is ultimately recovered by adulthood,
liver tissues by immunoprecipitation with antibodies for acetylated histone H3 [K9,14] and
trimethylated histone H3 [K9]. Quantification analysis on the immunoprecipitated solubilzed
even though deficiencies in body
DNA was carried out by real-time PCR via use of primers specific for the LXRE site on the
weight may still be apparent.
promoter regions of hepatic Cyp7a1. The relative level of immunoprecipitated genomic DNA
was normalized to the total genomic DNA. Results were expressed as the mean ⫾ SEM.*,
As evident from their body weight at
Significant difference (P ⬍ 0.05); n ⫽4 – 6/group, where each n represents an offspring
d 21, restoration of protein in the maderived from a different mother. RXR, Retinoid X receptor.
ternal diet at birth (e.g. LP3) resulted in
complete catch-up growth in these offspring, with no changes in the liver to
dysregulation. Uncovering these molecular mechanisms is
critical given that 50% of metabolic syndrome-related dis- body weight ratio. Moreover, they also exhibited eneases can be linked to adverse events in utero (10 –12). In hanced Cyp7a1 protein levels, contributing to the prevenidentifying some of the epigenetic mechanisms underlying tion of hypercholesterolemia. Given that during this pethe in utero origins of hypercholesterolemia, this study helps riod there is a high rate of replication, neogenesis, and

792

Sohi et al.

In Utero Origins of Hypercholesterolemia

Mol Endocrinol, May 2011, 25(5):785–798

apoptosis leading to extensive liver remodeling in the
newborn (39), it is not surprising that a restoration of
protein in the maternal diet during this developmental
window rescued hepatic growth and function. Other
studies have implicated the neonatal period as a period of
plasticity in liver development (23, 40). Raab et al. (23)
have demonstrated that in IUGR rats derived from uterine-ligated dams, neonatal administration of Exendin-4
(a GLP-1 analog), prevents the development of hepatic
oxidative stress and insulin resistance. Further understanding the molecular mechanisms underlying this plasticity could lead to improved therapies designed to enhance hepatic growth and function long term.
A LP diet during pregnancy and lactation (e.g. LP1/
LP2) was associated with hypercholesterolemia (⬃4.5
mM) at postnatal d 21 in both sexes. At this age, hepatic
Cyp7a1 expression in these offspring was reduced two
thirds compared with control. This is intriguing given that
Cyp7a1 has been previously demonstrated to display
maximal expression at postnatal d 21 (41, 42). A LP1/
LP2-induced increase in circulating cholesterol by 3 wk of
age is of considerable interest with regards to the early
development of cardiovascular disease. Interestingly,
when a LP diet was fed to nursing mothers fostering control diet offspring, circulating cholesterol levels was not
significantly different, highlighting the importance of the
in utero environment in the long-term regulation of cholesterol levels. In LP2 offspring at d 130, circulating and

hepatic cholesterol was significantly higher (⬃30%) in
the male LP2 offspring. The decrease in Cyp7a1 is likely
the major contributor to the observed 30% increase in
hepatic cholesterol given that there was no difference in
the protein levels of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (involved in cholesterol synthesis) and
the LDL receptor (involved in cholesterol flux).
The augmented circulating and hepatic cholesterol
observed in these LP2 offspring is similar to what is
observed in Cyp7a1-deficient mice and in humans with
a mutation in CYP7A1 (5, 43). This elevation in baseline
cholesterol in combination with other diet and lifestyle
factors (i.e. high-fat diet) could make these animals more
susceptible to hypertension and cardiovascular disease.
For example, LP2 female offspring that were fed a control
diet higher in carbohydrates after lactation exhibited elevated systolic blood pressure at 1 yr of age (33). Although
males were not examined in that study, it remains possible
from our study that the augmented cholesterol from as
early as 3 wk could collectively contribute to a similar or
worse phenotype. Moreover, the combination of impaired
glucose tolerance (31), visceral obesity (29), and augmented
cholesterol in these LP2 offspring would lead toward the
development of metabolic syndrome.
It is interesting to note that whereas LP2 offspring had
augmented cholesterol at d 130, neither LP1 nor LP3 offspring exhibited this phenotype. This is likely due to the fact
that a LP environment during development results in adap-
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FIG. 5. Quantitative RT-PCR mRNA level analysis of Jmjd2a (A and D), Jmjd2b (B and E), and Jmjd2c (C and F) in the livers of rat offspring derived
at embryonic d 19 (e19) and male rat offspring at postnatal d 21, respectively. RNA was extracted and reverse transcribed for quantitative RT-PCR.
mRNA level expression was assessed via Q-RT-PCR using primers specific for Jmjd2a, Jmjd2b, Jmjd2c, and Hprt. The relative levels of each mRNA
transcript were normalized to that of the levels of each Hprt mRNA transcript. Results were expressed as the mean ⫾ SEM. *, Significant difference
(P ⬍ 0.05); n ⫽ 4 –9/group at embryonic d 19, where each n represents an offspring derived from two different mothers and n ⫽ 5– 6/group at
postnatal d 21, where each n represents an offspring derived from a different mother.

Mol Endocrinol, May 2011, 25(5):785–798

mend.endojournals.org

793

tations that are better suited to a similar environment later
on in life (44). Therefore, when a switch is made to a 20%
protein diet after liver development (45) (e.g. LP2), the offspring become more susceptible to physiological disorders.
It was surprising to find that the LP3 animals had normal circulating cholesterol in our study, given previous
work that has demonstrated that rapid catch-up
growth in humans is more tightly associated with components of the metabolic syndrome (46). The answer
may be due to the differences in liver development and
the duration of the low-protein insult. Liver development in rodents and humans consists of embryonic cell
specification, budding, and then differentiation (45). In
rodents, liver differentiation develops later in gestation
with a large portion of it occurring in postnatal life. In

contrast, liver differentiation in humans is already occurring by early to midgestation (45). Therefore, at
birth the rat liver is less mature and has greater plasticity than the human liver. This makes the rat liver
more susceptible to further insult or recovery during
that period of neonatal life. This plasticity in liver development is evident in the LP3 offspring whereby
Cyp7a1 expression was restored at postnatal d 21 due
to increases in LXR␣ activation. This is in contrast to the
LP2 offspring, which did not exhibit alterations in LXR␣
binding to the Cyp7a1 promoter. Collectively, this would
suggest that it is the difference in the duration of the dietary
LP insult (LP2 ⫽ 43 d vs. LP3 ⫽ 21 d) throughout the crucial
stages of rat liver development that likely plays a greater role
in long-term liver impairment than catch-up growth.
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FIG. 6. The effect of LP1/LP2 (A and C) and LP3 (B and D) dietary regime on hepatic LXR␣ protein and binding levels to Cyp7a1 LXRE site in rat
offspring at postnatal d 21. Relative hepatic LXR␣ protein levels were determined using Western blot analysis. Total protein was isolated and LXR␣
protein was detected on a Western blot using the LXR␣ primary antibody. The LXR␣ protein level was quantified using densitometry and
normalized to that of ␤-actin protein levels. Relative hepatic LXR␣ binding levels to Cyp7a1 LXRE site were determined using ChIP analysis. ChIP
was carried out on snap-frozen liver tissues by immunoprecipitation with antibody specific for LXR␣. Quantification analysis on the
immunoprecipitated solubilized DNA was carried out by real-time PCR via use of primers specific for the LXRE site on the promoter regions of
hepatic Cyp7a1. The relative level of immunoprecipitated genomic DNA was normalized to the total genomic DNA. Results were expressed as the
mean ⫾ SEM.*, Significant difference (P ⬍ 0.05); n ⫽4 –7/group, where each n represents a single offspring derived from a different mother. RXR,
Retinoid X receptor.
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Given that this LP model leads to asymmetric IUGR (20),
and that this brain-sparing effect is associated with fetal
hypoxia (49, 50), this could conceivably mediate the observed decrease in JmjD2a expression. As a result, this
would lead to the observed hypermethylation and hypoacetylation surrounding the promoter of Cyp7a1 during development.
Recent studies in animal models have suggested that
perturbations to the maternal environment during pregnancy can lead to sex-specific, long-term consequences in
postnatal life. For example, LP2 offspring exhibited insulin resistance (35) and visceral obesity (29) exclusively in
the adult male offspring at postnatal d 130. In this study,
circulating cholesterol increased whereas a concomitant
decrease in Cyp7a1 protein levels and RNA polymerase II
recruitment was observed only in the adult male offspring
at postnatal d 130. Furthermore, the male-specific silencing of Cyp7a1 expression observed at d 130 was governed, in part, due to male-specific repressive changes in
posttranslational histone modifications surrounding the
active site of the Cyp7a1 promoter. Given that cholesterol
and Cyp7a1 expression are deregulated in both sexes at d
21, but only in males at d 130, it is unlikely that imprinting is involved. Instead, it is plausible that gender-specific
hormonal differences after lactation may mediate these
programmed effects. It has been postulated that sex steroids (e.g. estrogen) may offer the female some protective
effects against the development of these disease processes,
including elevated blood pressure (51). Evidence from
this comes from the aromatase knockout (ArKO) mouse,
which cannot synthesize endogenous estrogens due to disruption of the Cyp19 gene (52). ArKO females, when
challenged with a high-cholesterol diet, had higher circulating cholesterol and lower Cyp7a1 expression compared with wild-type females and males of either genotype (52), where estrogen replacement reversed the
hepatic steatosis (53). However, the stimulatory effects of
synthesizing estrogen may be only part of the reason for
the sexual dimorphism observed in LP2 offspring. Given
that LP2 males have suppressed levels of circulating testosterone compared with control males (35), it is conceivable that the loss of this male sex steroid may also underlie
the male-specific impairment of Cyp7a1 and cholesterol
catabolism. Aside from sex steroids, another important
difference in LP2 males and females in that study was
circulating basal insulin concentrations. LP2 male offspring at postnatal d 130 have 2-fold higher levels of
circulating insulin (35), which has been previously demonstrated to inhibit Cyp7a1 in both the rat hepatocytes
and streptozotocin-induced diabetic rats via decreases in
the binding of the transcription factors FoxO1 and
Smad3 to the promoter of Cyp7a1 (54). Moreover, stud-
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Epigenetic mechanisms have been previously demonstrated to underlie developmental programming of gene
transcription. However, investigation of the epigenetic
mechanisms linking an in utero insult to the development
of disease in postnatal life is limited (18, 19, 23, 24).
Because a conserved CpG island was not found in the
promoter region of the human and rodent Cyp7a1, it is
more likely that posttranslational histone modifications
may influence its long-term expression compared with
DNA methylation. In the present study, significant decreases in the acetylation and increases in methylation of
histone H3 [K9], promoting a repressive chromatin environment, were observed surrounding the hepatic Cyp7a1
promoter in LP2 male offspring at postnatal d 21. This
persisted into adulthood (d 130), long after the switch to
a control diet. The observed repressive chromatin environment correlated with decreased recruitment of RNA
polymerase II, diminished Cyp7a1 protein levels, and the
observed increases in circulating cholesterol. This is not
surprising because trichostatin A, a histone deacetylase
inhibitor, has been previously demonstrated to increase
Cyp7a1 expression and cholesterol metabolism when administered in mice (47). It is interesting to note that the
significant increase in histone H3 trimethylation at postnatal d 21 was preceded by a decrease in the expression of
the [K9] demethylase Jmjd2a during fetal life. This suggests that an early loss of demethylation in the fetal liver,
due to a LP diet, may initiate the enhanced trimethylation
of histone H3 observed in LP2 offspring.
Whereas an increase in the acetylation of histone H3
[K9,14] was observed surrounding the Cyp7a1 promoter
at embryonic d 19, recruitment of RNA polymerase II to
its promoter and Cyp7a1 protein levels were modestly
reduced. Moreover, increases in the overall trimethylation of histone H3 [K9] were not observed at this time in
development. Therefore in fetal life, the decreased expression of Cyp7a1 is likely also due to transcriptional mechanisms. Recently, it was demonstrated that a low-protein
diet in mice led to decreased expression of LXR␣ and
certain downstream target genes at embryonic d 19.5 as a
result of increased DNA methylation at LXR␣ promoter
(22). Therefore, the decrease in recruitment of RNA polymerase II to the Cyp7a1 promoter in the fetuses derived
from a LP diet could possibly be due to decreased recruitment of LXR␣ at the Cyp7a1 LXRE site.
To date, very little is known about the links between
malnutrition and epigenetic mechanisms during development, specifically with regards to the regulation of histonemodifying enzymes. One study looking at fetal surfactant
protein A expression demonstrated that lower oxygen tension in vitro can promote alterations in these enzymes,
leading to a repressive chromatin environment (48).
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was excised and frozen. Another subset of rats was allowed to
deliver spontaneously. The growth curves and food intake of
these offspring were monitored by measuring their body weight
and food consumption every third day. At both postnatal d 21,
the selected time for weaning, and at postnatal d 130, the pups
were also killed for blood and medial lobe liver tissue analysis.

Plasma lipid measurements
Measurements of total cholesterol and triglycerides from
plasma of all blood samples were automatically detected using
the COBAS analyzer (Roche, Mississauga, Ontario, Canada) at
St. Joseph’s Health Care (London, Ontario, Canada). For the
measurement of circulating cholesterol, cholesterol esters were
cleaved by cholesterol esterase and subsequently converted to
cholest-4-en-3-one and hydrogen peroxide by cholesterol oxidase. A colorimetric assay resulting from breakdown of hydrogen peroxide via the Trinder reaction allowed for the quantification of cholesterol levels.

Hepatic cholesterol measurements
To determine the total amount of cholesterol present in hepatic tissue, a chloroform-methanol (1:1) extraction was performed to extract and separate total cholesterol and phospholipids from aqueous matter. After samples were dried, the total
amount of cholesterol was determined by the Amplex Red Cholesterol Assay Kit (Invitrogen, Carlsbad, CA), which produces
resorufin as a cholesterol byproduct. This was measured using a
fluorescence spectrometer at 590 nm.

Real-time PCR analysis

Materials and Methods
Animals and dietary regimes
All procedures were performed in accordance with the guidelines set by the Canadian Council of Animal Care and upon
approval of the Animal Care Committee of the University of
Western Ontario. Female and male Wistar rats at breeding age
(250 g) were purchased from Charles River (La Salle, St-Constant, Quebec, Canada). These rats were housed in individual
cages and maintained at room temperature on a 12-h light, 12-h
dark cycle. For 3 wk, these rats were left to acclimatize to the
animal care facility, and their reproductive cycles were followed. At the onset of proestrus, these rats were mated. Impregnation was confirmed by the presence of sperm in the vaginal
smear the next morning.
Upon confirmation of impregnation (gestation d 1), the rats
were fed either a control diet containing 20% protein or a LP
diet containing 8% protein. The LP diet contained similar fat
content and was made isocaloric by the addition of carbohydrates (Bio-Serv, Frenchtown, NJ). At birth, the litter size was
reduced to eight animals (four females and four males), with
weights closest to the litter mean. This ensured a standard litter
size for all mothers. Four different dietary regimes were administered to these offspring (Table 1). Offspring derived from a
maternal LP diet were either administered the LP diet throughout postnatal life (LP1), until the end of lactation (LP2) or until
birth (LP3). Otherwise, they were given a control diet.
Food and water was provided ad libitum, and food intake
was recorded during pregnancy and in the offspring. At embryonic d 19, a subset of pregnant rats were killed, the weights of
the fetus, placenta, and liver were measured, and the fetal liver

Total RNA from Wistar rat medial lobe liver tissue was extracted at embryonic d 19, postnatal d 21, and postnatal d 130
by the one-step method of Chomczynski and Sacchi (58) (TRIzol, Invitrogen). RNA was treated with deoxyribonuclease to
remove any contaminating DNA. Of the total RNA, 4 g were
reverse transcribed to cDNA using random primers and Superscript II RNase H-reverse transcriptase (Invitrogen). Primer sets
directed against rat Jmjd2a, Jmjd2c, Jmjd2d, ␤-actin, and Hprt
(rRNA) were generated via Primer Express software (PE Applied
Biosystems, Boston, MA) based on published sequences (Table 2).
The relative abundance of each transcript was determined by realtime quantitative PCR as previously published (59). For the quantitative analysis of mRNA expression, the Bio-Rad CFX384 Real
Time System was employed using the DNA binding dye IQ

TABLE 2. Real-time PCR Primers
Gene
Jmjd2a

Forward,
Reverse,
Jmjd2b
Forward,
Reverse,
Jmjd2c
Forward,
Reverse,
Jmjd2d
Forward,
Reverse,
Hmg-CoA
Forward,
Reductase Reverse,
Ldlr
Forward,
Reverse,
Hprt
Forward,
Reverse,
␤-actin
Forward,
Reverse,

Primer (5ⴕ-3ⴕ)
GCG
AAC
GCG
GGG
ATG
CAT
GGG
GGG
TAC
CAG
GGG
TGG
TTG
AGC
ACG
TTG

AGC
ACC
AGC
ACC
GAG
GGG
GCA
CAT
ATC
GTT
TTC
TAT
CTC
AGG
AGG
GTT

AGG AGC TGG CAG AG
AGC GGG TGA TGG CG
TGG TGG AGC TGC GG
GTA CCC TCT TGG GC
GAG TTT CGG GAG TT
CTT TTT CTG GAT GT
GCC ACG AGC TTT CC
CAG CTC AGT CAG GG
CGT CTC CAG TCC AAA A
TCT TGT CGG TGC AA
CAT AGG GTT TCT GCT
ACT CGC TGC GGT CC
GAG ATG TCA TGA AGG A
TCA GCA AAG AAC TTA TAG
CCC AGA GCA AGA
ACA ATG CCG TGT TCA

Reference no.
NM 001107966
NM 001107966
BC161813
BC161813
BC158850
BC158850
NM 001079712
NM 001079712
NM 013134
NM 013134
NM 175762
NM 175762
NM 012583
NM 012583
NM 031144
NM 031144
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ies have now established that these hormones can influence posttranslational histone modifications. For example, the estrogen receptor has been demonstrated to bind
to coregulators (i.e. CREB-binding protein/p300, steroid
receptor coactivator-1, steroid receptor coactivator-2)
that enhance promoter-specific histone H3 acetylation,
leading to an active chromatin state surrounding the promoter regions of estrogen-responsive genes (55–57).
Therefore in LP2 females, it is conceivable that their histone code was altered at the promoter of Cyp7a1 via the
actions of these hormones.
In conclusion, our results demonstrate that LP dietinduced IUGR leading to augmented cholesterol in postnatal life results from permanent epigenetic silencing of
the hepatic Cyp7a1 promoter, via posttranslational histone modifications. Moreover, our study identifies the in
utero environment as a novel risk factor for cholesterol
dysregulation and aids our understanding of why a prevalence of metabolic syndrome-related diseases can be
linked to adverse events in fetal life. Given the plasticity of
the liver in fetal and neonatal life, further studies will
undoubtedly lead to early life dietary and/or drug intervention strategies to lower cholesterol and reduce the incidence of the metabolic syndrome in adulthood.
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ChIP
ChIP was performed on snap-frozen medial lobe liver tissue
excised at embryonic 19, postnatal d 21, and postnatal d 130
from male and female offspring derived from the control or LP2
dietary regime. ChIP was performed using a modification (60)
of previously published methods (61). Briefly, a small piece of
snap-frozen liver was homogenized and incubated with 1%
formaldehyde for 10 min at room temperature to cross link
proteins and DNA. Cross-linking was terminated by the addition of glycine (0.125 M, final concentration). The liver tissue
was washed once with cold PBS and placed in 500 l of sodium
dodecyl sulfate (SDS) lysis buffer (Millipore, Etobicoke, Ontario, Canada) with protease inhibitor cocktail (Roche). The
lysates were sonicated on ice to produce sheared, soluble chromatin. The lysates were diluted 10 times with the addition of
ChIP dilution buffer (Millipore) and aliquoted to 400-l
amounts. Each of the aliquots was precleared with protein A/G
Plus agarose beads (40 l, Millipore) at 4 C for 30 min. The
samples were microfuged at 12,500 rpm to pellet the beads, and
the supernatant containing the sheared chromatin was placed in
new tubes. The aliquots were incubated with 4 g of antibodies
against RNA polyermase II (catalog no. 05-623B), acetylated
histone H3 (K9,14, catalog no. 05-399), trimethylated histone
H3 (K9, catalog no. 07-442, all from Millipore), or LXR␣ (catalog no. sc-13068x, Santa Cruz Biotechnology, Inc., Santa
Cruz, CA) at 4 C overnight. Two aliquots were reserved as
controls, one incubated without antibody and the other with
nonimmune IgG (Millipore). Protein A/G Plus agarose beads
(60 l) were added to each tube, the mixtures incubated for 1 h
at 4 C, and the immune complexes collected by centrifugation.
The beads containing the immunoprecipitated complexes were
washed sequentially for 5 min in wash buffer I (20 mM Tris-HCl,
pH 8.1; 2 mM EDTA, 0.1% SDS, 1% Triton X-100, 150 mM
NaCl), wash buffer II (same as I, except containing 500 mM
NaCl), wash buffer III (10 mM Tris-HCl, pH 8.1; 1 mM EDTA;
1% Nonidet P-40; 1% deoxycholate; 0.25 M LiCl), and in 2⫻
Tris-EDTA buffer. The beads were eluted with 250 l elution
buffer (1% SDS, 0.1 mM NaHCO3 ⫹ 20 g salmon sperm
DNA) (Sigma-Aldrich, Oakville, Ontario, Canada) at room
temperature. This was repeated once and eluates were combined. Cross-linking of the immunoprecipitated chromatin
complexes and input controls (10% of the total soluble chromatin) was reversed by heating the samples at 65 C for 4 h.

Proteinase K (15 g, (Invitrogen) was added to each sample in
buffer (50 mM Tris-HCl, pH 8.5; 1% SDS; 10 mM EDTA) and
incubated for 1 h at 45 C. The DNA was purified by phenolchloroform extraction and precipitated in EtOH overnight at 20
C. Samples and input controls were diluted in 10 –100 l TrisEDTA buffer just before PCR. Real-time PCR was employed
using forward (5⬘-TGCTTTGGTCACTCAAGTTCA-3⬘) and
reverse (5⬘-GCAATTCCCCAAATCAAAGA-3⬘) primers that
amplify a ⫺164-bp to ⫹65-bp region encompassing the TATA
box and the Cyp7a1 initiation site (62), forward (5⬘-CGTAGCTCAGGCCTCTGCGCCCTT-3⬘) and reverse (5⬘-CTGGCACTGCAC-AAGAAGATGCGGCTG-’) primers that amplify a ⫺123-bp to ⫹53-bp region encompassing the TATA box
and the rat Gapdh initiation site (63), and forward (5⬘-GGCCGGGTAATGCTATTTTT-3⬘) and reverse (5⬘-CCGAAACAGTGGGTCTGACT-3⬘) primers that amplify a ⫺156-bp to
⫹25-bp region encompassing the rat Cyp7a1 LXRE site (⫺128
bp to ⫺81 bp) and the TATA box (PE Applied Biosystems,
Boston, MA) (62). Using serial dilutions of rat liver chromosomal DNA, these primers were demonstrated to have equal
efficiency in priming to their target sequences. Primers against
distal regions of the Cyp7a1 promoter were employed to ensure
this region has the greatest recruitment of RNA polymerase II.

Preparation of tissue membrane extracts and
immunoblot analysis
Wistar rat liver tissue membrane extracts were prepared using modifications of previously published methods (64). Briefly,
a small piece of snap-frozen medial lobe liver tissue was homogenized in a 1.2 ml of buffer A solution (250 mM sucrose, 2 mM
MgCl2, 20 mM Tris-HCl at overall pH 7.5) with protease inhibitor cocktail (Roche). The homogenate was centrifuged at
2000 ⫻ g for 10 min at 4 C. The supernatant was retained and
buffer A was added. This was centrifuged at 120,000 ⫻ g for 45
min at 4 C, and the pellet was retained as the membrane fraction, which was resuspended in 200 l of buffer B (80 mM NaCl,
2 mM CaCl2, 1% Triton X-100, 50 mM Tris-HCl at over-all pH
8) with protease inhibitor cocktail (Roche). Equal concentrations of membrane proteins normalized by colorimetric BCA
Protein Assay (Pierce Corp., Madison, WI), were fractionated in
gradient polyacrylamide gels (Invitrogen) and transferred onto
polyvinylidenedifluoride membrane (Millipore). Blots were
probed using Cyp7a1 rabbit polycolonal antibody (1:500, catalog no. sc-25536, Santa Cruz Biotechnology), LXR␣ (catalog
no. sc-13068x, Santa Cruz Biotechnology), and monoclonal
horseradish peroxidase-conjugated ␤-actin (1:50,000, catalog
no. A3854, Sigma-Aldrich) diluted in 5% milk-1⫻ Tris-buffered saline-Tween 20 buffer and with horseradish peroxidaseconjugated donkey antirabbit IgG (1:10,000, catalog no. 711035-152, Jackson ImmunoResearch Laboratories, West Grove,
PA) diluted in 5% milk-1⫻ Tris-buffered saline-Tween 20 buffer as the secondary antibody. Immunoreactive bands were visualized using an enhanced chemiluminescence detection system
(Thermo Scientific, Waltham, MA).

Statistics
All results were expressed as the mean of arbitrary values ⫾ the
The significance of differences (P ⬍ 0.05) between mean values was evaluated using the unpaired Student’s t test for results
from quantitative RT-PCR, ChIP, and immunoblot analysis. Two
and one-way ANOVA followed by a Bonferroni’s Multiple ComSEM.
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SYBER green supermix (Bio-Rad). The cycling conditions were
50 C for 2 min, 95 C for 10 min, followed by 45 cycles of 95 C
for 15 sec, and 60 C for 1 min. The cycle threshold was set at a
level where the exponential increase in PCR amplification was
approximately parallel between all samples. All primer sets produced amplicons of the expected size and sequence. We calculated the relative fold changes using the comparative cycle times
(Ct) method with rRNA (Hprt) or ␤-actin as the reference guide.
Over a wide range of known cDNA concentrations, all primer
sets were demonstrated to have good linear correlation (slope ⫽
⫺3.4) and equal priming efficiency for the different dilutions
compared with their Ct values (data not shown). Given that all
primer sets had equal priming efficiency, the ⌬Ct values (primer
internal control) for each primer set were calibrated to the experimental samples with the lowest transcript abundance (highest Ct value), and the relative abundance of each primer set
compared with calibrator was determined by the formula,
2⌬⌬Ct, in which ⌬⌬Ct is the calibrated Ct value.
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parison post hoc test, was used to evaluate significance of differences for results comparing the effect of all the dietary regimes.
15.
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